Acetyl Isovaleryl Market

Acetyl Isovaleryl Market Snapshot

The global acetyl isovaleryl market size is expected to be valued at US$ 9.1 Bn in 2032. Rising demand for acetyl isovaleryl for usage in the production of tablets, such as aspirin and paracetamol is likely to bode well for the market. As per FMI, the global acetyl isovaleryl market is set to reach US$ 4.6 Bn in 2022 and exhibit growth at a CAGR of 2.7% in the forecast period from 2022 to 2032.

Acetyl isovaleryl is considered to be a yellow liquid with a cheesy, buttery odor. It can be synthesized by using the bromination technique of mesityl oxide. It is then treated with sulfuric acid. The resulting liquid is utilized as a flavoring ingredient to prepare rum, pineapple, banana, cream, coffee, and cheese flavors.

Acetyl is a moiety in organic chemistry. It is a compound of multiple organic compounds, including acetylsalicylic acid, acetaminophen, neurotransmitter acetylcholine, acetic acid, acetylcysteine, and acetyl-CoA.

Acetyl organic compounds have showcased a high ability to cross the blood-brain barrier. These enable a given drug to reach one’s brain very quickly and surges the effectiveness of a particular dose. These also make the drug’s effects more intense.

Moreover, acetyl can be generated by using numerous methods. The utilization of acetyl chloride or acetic anhydride is one of the most commonly used methods to generate acetyl.

How is the Prevalence of Common Cold Driving the Acetyl Isovaleryl Market Growth?

The high demand for paracetamols, aspirins, and pain killers in both developed and developing countries is anticipated to push the acetyl isovaleryl market growth in future years. It is also extensively used in the production of several significant medicines.

The increasing prevalence of common cold caused by various types of viruses is likely to boost the need for over-the-counter cough medicines, including paracetamol to get relief from early symptoms. In emerging countries, it has driven the sales of paracetamol drugs for flu, cold, and cough. It is a major factor that is anticipated to bode well for the global market.

Which Factors May Hamper the Global Acetyl Isovaleryl Market Growth?

Taking a high dose of paracetamol or aspirin may lead to various side effects, such as insomnia, constipation, agitation, headache, and vomiting. Even at recommended dosages, the potential for liver damage exists. The risk is high in those individuals who drink three or more alcoholic beverages every day.

The availability of multiple brands and their usage in combination with novel ingredients to treat flu and common cold may confuse patients and lead to inadvertent double-ups in terms of dosing. This factor may also hamper the demand for acetyl isovaleryl in the upcoming years.

Nandini Roy Choudhury

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is the High Burden of Flu Pushing the Asia Pacific Acetyl Isovaleryl Market?

Asia Pacific is projected to generate the largest acetyl isovaleryl market share in the upcoming years. This growth is attributable to the high demand for pain management drugs and the rising prevalence of flu, as well as headaches in India and China. It is further propelling the consumption of paracetamol and aspirin as these help in the treatment of mild to moderate pain, including toothaches, osteoarthritis, headaches, flu aches, backaches, and menstrual periods.

Paracetamol is also considered to be a highly effective antipyretic that is used for reducing fever. The rising prevalence of numerous indicative conditions and the increasing usage of OTC drugs in remote areas are also expected to propel the Asia Pacific market.

Are Rising Cases of Migraine Augmenting the North America Acetyl Isovaleryl Market?

By region, North America is likely to remain in the second position in terms of share in the assessment period. Sales of acetyl isovaleryl in this region are estimated to surge owing to the increasing prevalence of migraine in the U.S. and Canada. The presence of a well-established healthcare infrastructure in these countries is another crucial factor that is likely to augment growth.

According to the Centers for Disease Control and Prevention (CDC), women were nearly twice as likely as men to have had a severe migraine or headache in the last 3 months in 2018 in the U.S. alone. This trend is set to continue throughout the forthcoming years, thereby fostering the North America market.

Market Competition

Some of the reputed companies in the global acetyl isovaleryl market include The Dow Chemical Company, BOC Sciences, TCI America, Parchem Fine and Specialty Chemicals, Durturust Animal Pharmaceutical Ltd., Penta Manufacturing Company, Fengchen Group Co, Ltd., Synerzine, Celanese Corporation, Wholechem, Eastman Chemical Company, Vigon International, Wacker Chemie, and BP among others.

The majority of the leading players in the market are aiming to invest huge sums in research and development activities to introduce innovative products. A few other companies are increasingly focusing on expanding their manufacturing facilities to cater to the high demand from various end-use industries. Meanwhile, some of the small-scale enterprises are joining hands with international companies to co-develop new products.

Report Scope

Key Segments Profiled in the Acetyl Isovaleryl Industry Survey

By Product Form:

• Liquid Form
• Powder Form

By End Use:

• Cosmetics
• Beverage
• Alcoholic Beverages
• Non-alcoholic Beverages
• Bakery Products
• Dairy Products
• Confectionery
• Pharmaceuticals
• Paints
• Furniture
• Others

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East and Africa